Cognitive & Neurotrophic · Research deep dive
Cerebrolysin: the cited literature
Every study referenced in the Cerebrolysin monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Cerebrolysin is studied at 5 mg – 30 mg per administration, typically once daily in 10–20 day courses. The reference walkthrough below maps each citation to what it actually showed.
References covered
Cerebrolysin and recovery after stroke (CARS): a randomized controlled trial
Stroke, 2016
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Cerebrolysin.